Kimberlee Gauvreau

Biographic Data

ID7056802
NAMEKimberlee Gauvreau
GIVEN NAMESKimberlee
FAMILY NAMEGauvreau
SIGNATUREGAUVREAU K
AFFILIATIONSBoston Children's Hospital
ORCID0000-0002-2597-3226
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2021
H-INDEX0

  • Outcomes in Establishing Individual Vessel Patency for Pediatric Pulmonary Vein Stenosis

    Open AccessRyan Callahan, Kimberlee Gauvreau et al.ARTICLEChildren2021

    The purpose of this study was to determine what patient and pulmonary vein characteristics at the diagnosis of intraluminal pulmonary vein stenosis (PVS) are predictive of individual vein outcomes. A retrospective, single-center, cohort sub-analysis of individual pulmonary veins of patients enrolled in the clinical trial NCT00891527 using imatinib mesylate +/- bevacizumab as adjunct therapy for the treatment of multi-vessel pediatric PVS between …

  • Pulmonary Vein Stenosis

    Open AccessJennifer Schramm, Sivakumar Sivalingam et al.ARTICLEChildren2021

    Pulmonary vein stenosis (PVS) is a rare, but high mortality and resource intensive disease caused by mechanical obstruction or intraluminal myofibroproliferation, which can be post-surgical or idiopathic. There are increasing options for management including medications, cardiac catheterization procedures, and surgery. We queried the International Quality Improvement Collaborative for Congenital Heart Disease (IQIC) database for cases of PVS and …

  • Clinical Syndromic Phenotypes and the Potential Role of Genetics in Pulmonary Vein Stenosis

    Open AccessAbbas H Zaidi, Jessica M Yamada et al.ARTICLEChildren2021

    Pulmonary vein stenosis (PVS) is a rare, frequently lethal disease with heterogeneous phenotypes and an unclear etiology. Limited studies have reported associations between PVS and congenital heart disease (CHD), chronic lung disease (CLD), and/or prematurity; however, to date, there have been no studies that report detailed clinical syndromic phenotypes and the potential role of genetics in PVS. An existing registry of multivessel PVS patients s…

  • Aspiration Is Associated with Poor Treatment Response in Pediatric Pulmonary Vein Stenosis

    Open AccessMaria Niccum, Ryan Callahan et al.ARTICLEChildren2021

    Intraluminal pulmonary vein stenosis is a disease with significant morbidity and mortality, though recent progress has been made using multimodal therapy with antiproliferative agents. The aim of this study was to evaluate the association between aspiration and poor treatment response in patients with intraluminal pulmonary vein stenosis. A retrospective, single-center cohort analysis was performed of patients treated with a combination of imatin…

  • Longer Exposure to Left-to-Right Shunts Is a Risk Factor for Pulmonary Vein Stenosis in Patients with Trisomy 21

    Open AccessConnie Choi, Kimberlee Gauvreau et al.ARTICLEChildren2021

    We conducted a study to determine whether patients born with Trisomy 21 and left-to-right shunts who develop pulmonary vein stenosis (PVS) have a longer exposure to shunt physiology compared to those who do not develop PVS. We included patients seen at Boston Children's Hospital between 15 August 2006 and 31 August 2017 born with Trisomy 21 and left-to-right shunts who developed PVS within 24 months of age. We conducted a retrospective 3:1 matche…